{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:40:03Z","timestamp":1762177203429,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.japh.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T21:45:02Z","timestamp":1560462302000},"page":"686-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Psychoactive medication use among older community-dwelling Americans"],"prefix":"10.1016","volume":"59","author":[{"given":"Yara K.","family":"Haddad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feijun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamta V.","family":"Karani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary A.","family":"Marcum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"Web-based Injury Statistics Query and Reporting System (WISQARS)","key":"10.1016\/j.japh.2019.05.001_bib1"},{"issue":"37","key":"10.1016\/j.japh.2019.05.001_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.15585\/mmwr.mm6537a2","article-title":"Falls and fall injuries among adults aged \u226565 years\u2014United States, 2014","volume":"65","author":"Bergen","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.japh.2019.05.001_bib3","first-page":"116","article-title":"Geriatric falls: injury severity is high and disproportionate to mechanism","volume":"50","author":"Sterling","year":"2001","journal-title":"J\u00a0Trauma"},{"issue":"4","key":"10.1016\/j.japh.2019.05.001_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/jgs.15304","article-title":"Medical costs of fatal and nonfatal falls in older adults","volume":"66","author":"Florence","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.japh.2019.05.001_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.maturitas.2013.02.009","article-title":"Risk factors for falls among older adults: a review of the literature","volume":"75","author":"Ambrose","year":"2013","journal-title":"Maturitas"},{"issue":"9","key":"10.1016\/j.japh.2019.05.001_bib6","first-page":"CD007146","article-title":"Interventions for preventing falls in older people living in the community","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.japh.2019.05.001_bib7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/gerona\/62.10.1172","article-title":"Medication as a risk factor for falls: critical systematic review","volume":"62","author":"Hartikainen","year":"2007","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"21","key":"10.1016\/j.japh.2019.05.001_bib8","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.japh.2019.05.001_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.japh.2019.05.001_bib10","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"9","key":"10.1016\/j.japh.2019.05.001_bib11","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.14930","article-title":"Opioids and other central nervous system\u2013active polypharmacy in older adults in the United States","volume":"65","author":"Gerlach","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.japh.2019.05.001_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen","year":"2015","journal-title":"BMC Geriatrics"},{"issue":"Suppl 21","key":"10.1016\/j.japh.2019.05.001_bib13","first-page":"11","article-title":"Anticholinergic effects of medication in elderly patients","volume":"62","author":"Tune","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.japh.2019.05.001_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1532-5415.1999.tb03843.x","article-title":"Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial","volume":"47","author":"Campbell","year":"1999","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.japh.2019.05.001_bib15","first-page":"127","article-title":"Prescription drug use in the elderly: a descriptive analysis","volume":"24","author":"Moxey","year":"2003","journal-title":"Health Care Financ Rev"},{"issue":"6","key":"10.1016\/j.japh.2019.05.001_bib16","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1377\/hlthaff.26.6.1735","article-title":"The impact of Medicare Part D on prescription drug use by the elderly","volume":"26","author":"Lichtenberg","year":"2007","journal-title":"Health Aff (Millwood)"},{"issue":"5","key":"10.1016\/j.japh.2019.05.001_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1377\/hlthaff.23.5.217","article-title":"Looking inside the nation\u2019s medicine cabinet: trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001","volume":"23","author":"Moeller","year":"2004","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"10.1016\/j.japh.2019.05.001_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","article-title":"Trends in opioid analgesic\u2013prescribing rates by specialty, U.S., 2007\u20132012","volume":"49","author":"Levy","year":"2015","journal-title":"Am J Prev Med"},{"issue":"7","key":"10.1016\/j.japh.2019.05.001_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40266-017-0470-x","article-title":"Falls-related drug use and risk of falls among older adults: a study in a US Medicare population","volume":"34","author":"Musich","year":"2017","journal-title":"Drugs Aging"},{"year":"2015","series-title":"Medicare Current Beneficiary Survey: CY 2013 cost and use files","key":"10.1016\/j.japh.2019.05.001_bib20"},{"issue":"1","key":"10.1016\/j.japh.2019.05.001_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ageing\/aft166","article-title":"Drug cessation in complex older adults: time for action","volume":"43","author":"van der Cammen","year":"2014","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.japh.2019.05.001_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4212\/cjhp.v66i3.1261","article-title":"Deprescribing: what is it and what does the evidence tell us?","volume":"66","author":"Thompson","year":"2013","journal-title":"Can J Hosp Pharm"},{"issue":"1","key":"10.1016\/j.japh.2019.05.001_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1532-5415.2010.03234.x","article-title":"Summary of the Updated American Geriatrics Society\/British Geriatrics Society clinical practice guideline for prevention of falls in older persons","volume":"59","year":"2011","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.japh.2019.05.001_bib24","first-page":"250","article-title":"The role of pharmacists in preventing falls among America\u2019s older adults","volume":"4","author":"Karani","year":"2016","journal-title":"Front Pub Health"},{"issue":"649","key":"10.1016\/j.japh.2019.05.001_bib25","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.3399\/bjgp16X685669","article-title":"Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study","volume":"66","author":"Reeve","year":"2016","journal-title":"Br J Gen Pract"},{"issue":"9","key":"10.1016\/j.japh.2019.05.001_bib26","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/jgs.12418","article-title":"People\u2019s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe","volume":"61","author":"Reeve","year":"2013","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.japh.2019.05.001_bib27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.sapharm.2016.08.006","article-title":"Community-dwelling older people\u2019s attitudes towards deprescribing in Canada","volume":"13","author":"Sirois","year":"2017","journal-title":"Res Social Admin Pharm"},{"issue":"6","key":"10.1016\/j.japh.2019.05.001_bib28","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.japh.2019.05.001_bib29","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.3390\/ijerph111010967","article-title":"New roles for pharmacists in community mental health care: a narrative review","volume":"11","author":"Rubio-Valera","year":"2014","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.japh.2019.05.001_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40266-014-0157-5","article-title":"Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study","volume":"31","author":"Dalleur","year":"2014","journal-title":"Drugs Aging"},{"issue":"8","key":"10.1016\/j.japh.2019.05.001_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A\u00a0drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.japh.2019.05.001_bib32","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/jgs.13647","article-title":"Concordance between anticholinergic burden scales","volume":"63","author":"Naples","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119302171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119302171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:45:42Z","timestamp":1761543942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319119302171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1544319119302171"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2019.05.001","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychoactive medication use among older community-dwelling Americans","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}